title: Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.
abstract: Trisomy 21 (Down syndrome, DS) is the most common genetic cause of developmental cognitive deficits, and the so-called Down syndrome critical region (DSCR) has been proposed as a major determinant of this phenotype. The regions on human chromosome 21 (Hsa21) are syntenically conserved on mouse chromosome 10 (Mmu10), Mmu16 and Mmu17. DSCR is conserved between the Cbr1 and Fam3b genes on Mmu16. Ts65Dn mice carry three copies of ∼100 Hsa21 gene orthologs on Mmu16 and exhibited impairments in the Morris water maze and hippocampal long-term potentiation (LTP). Converting the Cbr1-Fam3b region back to two copies in Ts65Dn mice rescued these phenotypes. In this study, we performed similar conversion of the Cbr1-Fam3b region in Dp(16)1Yey/+ mice that is triplicated for all ∼115 Hsa21 gene orthologs on Mmu16, which also resulted in the restoration of the wild-type phenotypes in the Morris water maze and hippocampal LTP. However, converting the Cbr1-Fam3b region back to two copies in a complete model, Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+, failed to yield the similar phenotypic restorations. But, surprisingly, converting both the Cbr1-Fam3b region and the Hsa21 orthologous region on Mmu17 back to two copies in the complete model did completely restore these phenotypes to the wild-type levels. Our results demonstrated that the Hsa21 orthologous region on Mmu17 is a major determinant of DS-related developmental cognitive deficits. Therefore, the inclusion of the three copies of this Hsa21 orthologous region in mouse models is necessary for unraveling the mechanism underlying DS-associated developmental cognitive deficits and for developing effective interventions for this clinical manifestation.
authors.affiliation: Department of Physiology and Pathophysiology, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
authors.forename: Li
authors.initials: L
authors.lastname: Zhang
authors.forename: Kai
authors.initials: K
authors.lastname: Meng
authors.forename: Xiaoling
authors.initials: X
authors.lastname: Jiang
authors.forename: Chunhong
authors.initials: C
authors.lastname: Liu
authors.forename: Annie
authors.initials: A
authors.lastname: Pao
authors.forename: Pavel V
authors.initials: PV
authors.lastname: Belichenko
authors.forename: Alexander M
authors.initials: AM
authors.lastname: Kleschevnikov
authors.forename: Sheena
authors.initials: S
authors.lastname: Josselyn
authors.forename: Ping
authors.initials: P
authors.lastname: Liang
authors.forename: Ping
authors.initials: P
authors.lastname: Ye
authors.forename: William C
authors.initials: WC
authors.lastname: Mobley
authors.forename: Y Eugene
authors.initials: YE
authors.lastname: Yu
mesh_terms: D000429:Alcohol Oxidoreductases / Q000235:genetics; D000818:Animals; D002891:Chromosomes, Human, Pair 21; D003072:Cognition Disorders / Q000235:genetics*; D016207:Cytokines / Q000235:genetics; D004195:Disease Models, Animal; D004314:Down Syndrome / Q000235:genetics*; D006624:Hippocampus / Q000502:physiology; D006801:Humans; D017774:Long-Term Potentiation / Q000235:genetics; D018782:Maze Learning; D008569:Memory Disorders / Q000235:genetics; D051379:Mice; D008817:Mice, Mutant Strains; D009363:Neoplasm Proteins / Q000235:genetics
chemical_list: D016207:Cytokines; C577825:FAM3B protein, human; D009363:Neoplasm Proteins; D000429:Alcohol Oxidoreductases; C531129:CBR1 protein, human
references.citation: Hum Mol Genet. 2009 Dec 15;18(24):4756-69
references.pmid: 19783846
references.citation: Biomed Pharmacother. 1994;48(5-6):247-52
references.pmid: 7999986
references.citation: J Neurosci. 2004 Sep 15;24(37):8153-60
references.pmid: 15371516
references.citation: Neuropharmacology. 1997 Nov-Dec;36(11-12):1549-54
references.pmid: 9517425
references.citation: Mol Neurobiol. 2010 Jun;41(2-3):129-37
references.pmid: 20213343
references.citation: J Psychopharmacol. 2011 Aug;25(8):1030-42
references.pmid: 21693554
references.citation: Trends Pharmacol Sci. 2010 Feb;31(2):66-73
references.pmid: 19963286
references.citation: Hum Mol Genet. 2007 Jun 1;16(11):1359-66
references.pmid: 17412756
references.citation: Science. 2004 Oct 22;306(5696):687-90
references.pmid: 15499018
references.citation: Mamm Genome. 2011 Dec;22(11-12):674-84
references.pmid: 21953411
references.citation: Prog Clin Biol Res. 1990;360:263-80
references.pmid: 2147289
references.citation: Nat Genet. 1995 Oct;11(2):177-84
references.pmid: 7550346
references.citation: Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):719-34
references.pmid: 16783527
references.citation: Eur J Hum Genet. 2009 Apr;17(4):454-66
references.pmid: 19002211
references.citation: Development. 2011 Jun;138(12):2543-54
references.pmid: 21610031
references.citation: Child Dev. 2003 Jan-Feb;74(1):75-93
references.pmid: 12625437
references.citation: Mol Biol Cell. 2005 Aug;16(8):3562-73
references.pmid: 15917294
references.citation: Hum Mol Genet. 2007 Apr 1;16(7):774-82
references.pmid: 17339268
references.citation: Nature. 1993 Jan 7;361(6407):31-9
references.pmid: 8421494
references.citation: Pharmacol Rev. 1998 Dec;50(4):723-60
references.pmid: 9860808
references.citation: Eur J Biochem. 2000 Oct;267(19):5830-6
references.pmid: 10998041
references.citation: J Physiol Pharmacol. 2005 Mar;56 Suppl 2:15-34
references.pmid: 16077188
references.citation: Brain Res. 2010 Dec 17;1366:162-71
references.pmid: 20932954
references.citation: Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12031-6
references.pmid: 19597142
references.citation: Science. 1999 Sep 17;285(5435):1870-4
references.pmid: 10489359
references.citation: Psychopharmacology (Berl). 2009 Jan;202(1-3):419-43
references.pmid: 18709359
references.citation: J Neurosci. 2009 May 6;29(18):5938-48
references.pmid: 19420260
references.citation: J Clin Invest. 2013 Jan;123(1):348-61
references.pmid: 23202733
references.citation: Ment Retard Dev Disabil Res Rev. 2000;6(2):84-95
references.pmid: 10899801
references.citation: Nature. 2006 Jun 1;441(7093):646-50
references.pmid: 16511445
references.citation: J Neurosci. 2013 Feb 27;33(9):3953-66
references.pmid: 23447605
references.citation: Adv Pharmacol. 2010;58:397-426
references.pmid: 20655490
references.citation: Proc Natl Acad Sci U S A. 1994 May 24;91(11):4997-5001
references.pmid: 8197171
references.citation: Eur J Hum Genet. 1993;1(2):114-24
references.pmid: 8055322
references.citation: Am J Hum Genet. 1990 Aug;47(2):236-46
references.pmid: 2143053
references.citation: J Int Neuropsychol Soc. 1996 Mar;2(2):159-76
references.pmid: 9375201
references.citation: Mamm Genome. 2011 Dec;22(11-12):685-91
references.pmid: 21953412
references.citation: Lancet. 2012 Feb 11;379(9815):528-36
references.pmid: 22236802
references.citation: J Neurosci. 2012 Jul 4;32(27):9217-27
references.pmid: 22764230
references.citation: Nat Neurosci. 2007 Apr;10(4):411-3
references.pmid: 17322876
references.citation: Eur J Neurosci. 2009 Jun;29(11):2137-44
references.pmid: 19490087
references.citation: Hum Mol Genet. 2010 Jul 15;19(14):2780-91
references.pmid: 20442137
references.citation: J Cell Sci. 2009 May 15;122(Pt 10):1574-83
references.pmid: 19383720